Halt Medical Inc., a medical device company that developed the minimally invasive AcessaTM procedure for the treatment of symptomatic uterine fibroids, completed Chapter 11 bankruptcy proceedings that resulted in a sale of the company as a going concern. Our firm represented Halt Medical in the matter.